» Authors » Takamasa Murosaki

Takamasa Murosaki

Explore the profile of Takamasa Murosaki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 27
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Murosaki T, Sato T, Nagatani K, Sato K, Minota S
Int J Rheum Dis . 2020 Sep; 23(11):1587-1593. PMID: 32996696
Aim: The use of an immunosuppressant is recommended as a treatment for remission induction in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). However, the immunosuppressant is sometimes discontinued due to an...
2.
Matsuzono K, Furuya K, Igarashi T, Horikiri A, Murosaki T, Chi D, et al.
J Thromb Thrombolysis . 2020 Apr; 49(4):681-684. PMID: 32253708
Cerebral amyloid angiopathy-related inflammation is a syndrome of reversible encephalopathy with cerebral amyloid angiopathy, however the pathology is not well understood. We clear a part of the pathology through the...
3.
Shima N, Murosaki T, Yamamoto S, Miyanaga A, Kusaka H, Nagatani K, et al.
Case Rep Rheumatol . 2019 May; 2019:4156781. PMID: 31110833
A 70-year-old man with systemic lupus erythematosus (SLE) presented with simultaneous right oculomotor nerve palsy and right facial nerve palsy. Brain magnetic resonance imaging and cerebrospinal fluid analysis revealed no...
4.
Shima N, Murosaki T, Nagashima T, Iwamoto M, Amano Y, Nakano N, et al.
Intern Med . 2017 Aug; 56(15):2063-2066. PMID: 28768982
A 68-year-old man presented with polyarthritis, proximal muscle weakness, and erythema of the face, arms, neck, and anterior chest that resembled the V-neck sign. Initially, dermatomyositis (DM) was considered because...
5.
Murosaki T, Nagatani K, Sato T, Akiyama Y, Ushijima K, Lefor A, et al.
Mod Rheumatol . 2016 Jul; 27(3):411-416. PMID: 27435295
Objectives: The objective of this study is to evaluate the pharmacokinetics and pharmacodynamics of methotrexate-polyglutamates (MTX-PGs) in erythrocytes in patients with rheumatoid arthritis and correlate them with the efficacy. Methods:...
6.
Murosaki T, Sato T, Akiyama Y, Nagatani K, Minota S
Mod Rheumatol . 2016 Jun; 27(1):95-101. PMID: 27320904
Objective: To correlate the serotype specificity to myeloperoxidase (MPO) and proteinase-3 (PR3) with clinical characteristics in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Methods: Clinical characteristics and outcomes of patients with...
7.
Murosaki T, Mori K, Nagashima T, Minota S
Intern Med . 2015 Mar; 54(3):357-8. PMID: 25748750
No abstract available.
8.
Murosaki T, Nagashima T, Honne K, Aoki Y, Minota S
Int J Rheum Dis . 2014 Mar; 17(4):476-8. PMID: 24618393
No abstract available.
9.
Murosaki T, Nagashima T, Aoki Y, Imai Y, Iwamoto M, Minota S
Intern Med . 2012 Nov; 51(22):3181-3. PMID: 23154729
A 59-year-old woman with a 10-year history of rheumatoid arthritis (RA) presented with chronic ulcers on both feet while undergoing treatment with etanercept. Rheumatoid vasculitis (RV) was diagnosed, and the...
10.
Murosaki T, Nagashima T, Matsumoto K, Minota S
Intern Med . 2012 Jun; 51(11):1451. PMID: 22687866
No abstract available.